Aberdeen Group
SNDX icon

Aberdeen Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Aberdeen Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.7M Sell
286,969
-85,823
-23% -$1.86M 0.01% 657
2025
Q4 		$7.83M Hold
372,792
– – 0.01% 647
2025
Q3 		$5.74M Buy
372,792
+69,366
+23% +$908K 0.01% 687
2025
Q2 		$2.84M Buy
303,426
+170,993
+129% +$1.88M ﹤0.01% 757
2025
Q1 		$1.63M Buy
132,433
+33,093
+33% +$467K ﹤0.01% 777
2024
Q4 		$1.31M Buy
+99,340
New +$1.7M ﹤0.01% 800
2021
Q4 		– Sell
-14,248
Closed -$272K – 1068
2021
Q3 		$272K Buy
+14,248
New +$237K ﹤0.01% 1010

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return